Expert Consensus on Mesenchymal Stem Cells in Treatment of COVID-19 (Beijing, 2021)National Clinical Research Center for Infectious Disease, Chinese Society of Infectious Diseases, Chinese Medical Association, Biotherapy Committee, Chinese Research Hospital Association99-106
HIV associated neurocognitive disorder: recent advances in pathogenesis, diagnosis and treatmentWEI Jia-qi, Zhang Tong107-111
Clinical study progress of stem cell therapy for end-stage liver diseaseYU Ying-ying, WANG Fu-sheng, SHI Ming112-116
MicroRNA-27a suppresses HBV replication by targeting HBx mRNADAI Xiao-peng, SONG Bing, NIU Xiao-ying, GE Li-na, ZHANG Li, JIAO Yan-mei, FU Zhan-jiang, CUI Cheng117-123
Comparison of T lymphocyte response to HBV in acute and chronic HIV infectionZHU Zhi-qiang, SONG Bing, JIANG Tai-yi, WANG Wen, ZHANG Yu124-126
Omics prediction analysis of COVID-19 treatment with cidofovirZHI Peng, ZHANG Hao-min, Wang Yi-xing, CHI Xiao-hua, CHEN Hao-ran, CHEN Xi-meng, ZHANG Jun-dong, LI Zhuo-yang, LIU Ge-liang, YANG Bo, YE Fang, LU Xue-chun127-132
Analysis on characteristics of heart related assessment index in COVID-19TONG Yu-wei, CAI Shui-jiang, XIE Zhi-wei, LI Yue-ping, CAI Wei-ping, LEI Chun-liang133-135,159
Efficacy of endoscopy combined with terlipressin or somatostatin for esophageal gastric varices bleedingMA Xue-mei, CHU Jin-dong, REN Hui, WU Qin, ZHANG Wen-hui, SHEN Li-jun, WANG Yan-ling, LIU Bo, BI Qian, WU Li-bing, CHI Chun-sheng, YAN Li-ping, LIU Zi-shuai, YU Xiao-li, LU Zheng, JIN Bo136-139
Effect of PE combined with DPMAS on survival of patients with liver cirrhosis complicated with chronic and acute liver failureQIN Wei, ZHU Su-ping, ZHENG Yan-li, HUO Yu-ling, WANG Dan140-143,147
Incidence and risk factors of renal injury in HIV/AIDS patients in XinjiangQIAN Qian-qian, LU Zhi-wu, Dilixiati·Alimu, DU Dan-dan, Zulimila, SHU Zhan-jun144-147